Canine ventricular myocytes possess a renin-angiotensin system that is upregulated with heart failure

L Barlucchi, A Leri, DE Dostal, F Fiordaliso… - Circulation …, 2001 - Am Heart Assoc
L Barlucchi, A Leri, DE Dostal, F Fiordaliso, H Tada, TH Hintze, J Kajstura, B Nadal-Ginard…
Circulation research, 2001Am Heart Assoc
Ventricular pacing leads to a dilated myopathy in which cell death and myocyte hypertrophy
predominate. Because angiotensin II (Ang II) stimulates myocyte growth and triggers
apoptosis, we tested whether canine myocytes express the components of the renin-
angiotensin system (RAS) and whether the local RAS is upregulated with heart failure. p53
modulates transcription of angiotensinogen (Aogen) and AT1 receptors in myocytes, raising
the possibility that enhanced p53 function in the decompensated heart potentiates Ang II …
Abstract
—Ventricular pacing leads to a dilated myopathy in which cell death and myocyte hypertrophy predominate. Because angiotensin II (Ang II) stimulates myocyte growth and triggers apoptosis, we tested whether canine myocytes express the components of the renin-angiotensin system (RAS) and whether the local RAS is upregulated with heart failure. p53 modulates transcription of angiotensinogen (Aogen) and AT1 receptors in myocytes, raising the possibility that enhanced p53 function in the decompensated heart potentiates Ang II synthesis and Ang II–mediated responses. Therefore, the presence of mRNA transcripts for Aogen, renin, angiotensin-converting enzyme, chymase, and AT1 and AT2 receptors was evaluated by reverse transcriptase–polymerase chain reaction in myocytes. Changes in the protein expression of these genes were then determined by Western blot in myocytes from control dogs and dogs affected by congestive heart failure. p53 binding to the promoter of Aogen and AT1 receptor was also determined. Ang II in myocytes was measured by ELISA and by immunocytochemistry and confocal microscopy. Myocytes expressed mRNAs for all the constituents of RAS, and heart failure was characterized by increased p53 DNA binding to Aogen and AT1. Additionally, protein levels of Aogen, renin, cathepsin D, angiotensin-converting enzyme, and AT1 were markedly increased in paced myocytes. Conversely, chymase and AT2 proteins were not altered. Ang II quantity and labeling of myocytes increased significantly with cardiac decompensation. In conclusion, dog myocytes synthesize Ang II, and activation of p53 function with ventricular pacing upregulates the myocyte RAS and the generation and secretion of Ang II. Ang II may promote myocyte growth and death, contributing to the development of heart failure.
Am Heart Assoc